Akebia Therapeutics
AKBA
#7373
Rank
A$0.66 B
Marketcap
A$2.51
Share price
-0.60%
Change (1 day)
-12.59%
Change (1 year)

Market capitalization of Akebia Therapeutics (AKBA)

Market cap: A$0.66 Billion

As of December 2025 Akebia Therapeutics has a market cap of A$0.66 Billion. This makes Akebia Therapeutics the world's 7373th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Akebia Therapeutics from 2014 to 2025

End of year Market Cap

Year Marketcap Change
2025A$0.66 B-2.63%
2024A$0.68 B99.49%
2023A$0.34 B119.82%
2022A$0.15 B-71.4%
2021A$0.54 B3.63%
2020A$0.52 B-52.08%
2019A$1.09 B19.7%
2018A$0.91 B1.91%
2017A$0.90 B62.67%
2016A$0.55 B1.78%
2015A$0.54 B87.69%
2014A$0.28 B

End of Day market cap according to different sources

On Dec 19th, 2025 the market cap of Akebia Therapeutics was reported to be:

A$0.66 Billion
by Nasdaq info icon info icon
A$0.66 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Amgen
AMGN
A$266.52 B 39,919.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$394.71 B 59,165.92%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Johnson & Johnson
JNJ
A$751.72 B 112,771.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
A$1.44 B 116.30%๐Ÿ‡บ๐Ÿ‡ธ USA